Invesco Health Care Fund Class R6 (GGHSX)
NASDAQ · Mutual Fund · Delayed Price · Currency is USD
40.73
+0.34 (0.84%)
At close: Feb 13, 2026

GGHSX Holdings Information

GGHSX is a mutual fund with a total of 78 individual holdings. The top holdings are Eli Lilly and Company stock at 9.70%, Boston Scientific at 6.53%, AbbVie at 5.04%, Cencora at 4.66%, and AstraZeneca at 4.24%.

Total Holdings
78
Top 10 Percentage
44.66%
Asset Class
Equity
Fund Category
Health
Assets
1.23B
Forward PE Ratio
22.72

Breakdown by Sector

Top 25 Holdings

No.SymbolName WeightShares
1LLYEli Lilly and Company9.70%113,267
2BSXBoston Scientific Corporation6.53%859,229
3ABBVAbbVie Inc.5.04%277,017
4CORCencora, Inc.4.66%173,307
5AZNAstraZeneca PLC4.24%578,798
6ARGXargenx SE3.55%52,976
7GILDGilead Sciences, Inc.3.30%337,004
8MCKMcKesson Corporation3.11%47,553
9WELLWelltower Inc.2.33%157,530
10THCTenet Healthcare Corporation2.21%139,424
11HCAHCA Healthcare, Inc.2.11%56,838
12ISRGIntuitive Surgical, Inc.2.05%45,537
13ALNYAlnylam Pharmaceuticals, Inc.1.81%57,138
14GHGuardant Health, Inc.1.70%208,295
15INSMInsmed Incorporated1.67%120,502
16ASNDAscendis Pharma A/S1.61%94,558
17TMOThermo Fisher Scientific Inc.1.61%34,797
18IDXXIDEXX Laboratories, Inc.1.57%29,150
19NTRANatera, Inc.1.57%86,013
20UNHUnitedHealth Group Incorporated1.56%59,237
21EHCEncompass Health Corporation1.53%180,367
22SWX: LONNLonza Group AG1.48%27,470
23BTSGBrightSpring Health Services, Inc.1.44%482,157
24PODDInsulet Corporation1.36%60,208
25BBIOBridgeBio Pharma, Inc.1.32%216,227
Showing 25 of 78 holdings
Subscribe to see the full list
As of Dec 31, 2025